{
    "2021-01-08": [
        [
            {
                "time": "2021-01-08",
                "original_text": "晚间重要公告2021年1月8日星期五美年健康(002044.SZ)：实控人增持计划完成累计增持500.05万股",
                "features": {
                    "keywords": [
                        "美年健康",
                        "实控人",
                        "增持",
                        "500.05万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-08",
                "original_text": "凯雷领投，和誉医药D轮融资1.23亿美元！专注于肿瘤治疗领域",
                "features": {
                    "keywords": [
                        "凯雷",
                        "和誉医药",
                        "D轮融资",
                        "1.23亿美元",
                        "肿瘤治疗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-08",
                "original_text": "凯雷领投中国领先创新生物科技公司和誉医药D轮融资",
                "features": {
                    "keywords": [
                        "凯雷",
                        "和誉医药",
                        "D轮融资",
                        "生物科技"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-08",
                "original_text": "手握1.6万亿的PE巨头凯雷，瞄准了中国的这一赛道",
                "features": {
                    "keywords": [
                        "凯雷",
                        "PE巨头",
                        "1.6万亿",
                        "中国赛道"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "投资",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}